COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021.

Anat AchironMark DolevShay MenascuDaniela-Noa ZoharSapir Dreyer-AlsterShmuel MironEmanuel ShirbintDavid MagalashviliShlomo FlechterUri GivonDiana GuberYael SternMichael PolliackRina FalbMichael Gurevich

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)

COVID-19 BNT162b2 vaccine proved safe for MS patients. No increased risk of relapse activity was noted.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
mass spectrometry
multiple sclerosis
peritoneal dialysis
ms ms
patient reported outcomes